Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.30 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.30 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propylene Oxide SCHEMBL5703388 | 1.00 | ALDH1A1 (0.50) | ALDH1A1CHRM2CHRM5CHRM3CHRM4 | |
| Propylene Oxide SCHEMBL27902062 | 1.00 | ALDH1A1 (0.50) | ALDH1A1CHRM2CHRM5CHRM3CHRM4 | |
| Tetrahydrofuran SCHEMBL209705 | 0.97 | — | — | |
| Tetrahydrofuran SCHEMBL893856 | 0.94 | ALDH1A1 (0.50) | ALDH1A1CHRM2CHRM5CHRM3CHRM4 | |
| Tetrahydrofuran SCHEMBL15375263 | 0.94 | ALDH1A1 (0.50) | ALDH1A1CHRM2CHRM5CHRM3CHRM4 | |
| Tetrahydrofuran SCHEMBL27500162 | 0.84 | ALDH1A1 (0.40) | ALDH1A1 | |
| Tetrahydrofuran SCHEMBL7884538 | 0.84 | ALDH1A1 (0.40) | ALDH1A1CHRM2CHRM5CHRM3CHRM4 | |
| Propylene Oxide SCHEMBL6250805 | 0.83 | — | — | |
| Cyclopentane SCHEMBL29243213 | 0.83 | — | — | |
| Propylene Oxide SCHEMBL27940502 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1677901-A1 | NOVEL OIL-IN-WATER EMULSIFIERS | THE LUBRIZOL CORPORATION (US) | 2006-07-12 | — | — | EP | disclosed |
| US-7045580-B2 | Modified polyoxyalkylene glycoll hydrophilic, lipiphilic balance | THE LUBRIZOL CORPORATION (US) | 2006-05-16 | — | — | US | disclosed |
| WO-2005042140-A1 | NOVEL OIL-IN-WATER EMULSIFIERS | THE LUBRIZOL CORPORATION (US) | 2005-05-12 | — | — | WO | disclosed |
| US-20050084466-A1 | Novel oil-in-water emulsifiers | THE LUBRIZOL CORPORATION, A CORPORATION OF THE STATE OF OHIO (US) | 2005-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050084466-A1 | Novel oil-in-water emulsifiers | AQP1, AQP3, AQP4 | ALDH1A1 836/4885CHRM2 672/4885CHRM5 669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.